Published in Biochem Biophys Res Commun on January 06, 1998
Changes in maternal liver Cyp2c and Cyp2d expression and activity during rat pregnancy. Biochem Pharmacol (2008) 0.93
Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem (2000) 3.23
CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest (2000) 3.17
Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis (2001) 2.63
The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Mol Pharmacol (1999) 2.49
Hepatitis C virus in intravenous drug users. Med J Aust (1990) 2.33
Androgen-induced hepatoma. Lancet (1975) 2.21
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology (1998) 2.19
The cost effectiveness of alpha interferon in the treatment of chronic active hepatitis C. Med J Aust (1994) 2.15
Barriers to hepatitis C transmission within breathing systems: efficacy of a pleated hydrophobic filter. Anaesth Intensive Care (1997) 2.14
In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576. Cancer Res (2001) 1.95
Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology (1996) 1.83
Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. Am J Physiol Gastrointest Liver Physiol (2001) 1.79
Which patients with hepatitis C develop liver complications? Hepatology (2000) 1.73
Antipyrine clearance and response to interferon treatment in patients with chronic active hepatitis C. Hepatology (1995) 1.41
Confusion, cortical blindness and fever. Med J Aust (1995) 1.38
Evaluation of the off-label usage of rituximab in a large teaching hospital in New South Wales. Intern Med J (2007) 1.37
Enhanced drug metabolism in cigarette smokers. Br Med J (1976) 1.31
Do medical courses adequately prepare interns for safe and effective prescribing in New South Wales public hospitals? Intern Med J (2009) 1.20
Herbal hepatotoxicity: an expanding but poorly defined problem. J Gastroenterol Hepatol (2000) 1.19
Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease. Hepatology (1995) 1.18
Institutional rearing, parenting difficulties and marital support. Psychol Med (1984) 1.15
Drug metabolism in liver disease: activity of hepatic microsomal metabolizing enzymes. Clin Pharmacol Ther (1979) 1.13
Drug-induced cholestasis. Semin Gastrointest Dis (2001) 1.13
PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice. Br J Cancer (2012) 1.10
The mechanism of cyclosporine toxicity induced by clarithromycin. Br J Clin Pharmacol (1997) 1.08
Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes. J Clin Endocrinol Metab (1998) 1.07
Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob/ob mice, and fa/fa Zucker rats. Biochem Biophys Res Commun (1999) 1.06
Effects of hepatitis G virus coinfection on severity of hepatitis C: relationship to risk factors and response to interferon treatment. J Gastroenterol Hepatol (1998) 1.06
Bile acid synthesis in primary cultures of rat and human hepatocytes. Hepatology (1998) 1.03
Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment. J Viral Hepat (1995) 1.01
Does hepatitis C virus play a role in "non-viral" chronic liver disease? Med J Aust (1990) 1.01
Inhibition of theophylline metabolism by interferon. Lancet (1987) 1.01
Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism. Gastroenterology (1978) 1.01
Incorporation of exogenous heme into hepatic cytochrome P-450 in vivo. J Biol Chem (1979) 0.99
Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease. J Viral Hepat (2008) 0.98
Evaluation of Cal antibody in pleural biopsy material. Lancet (1983) 0.97
Management of chronic hepatitis C virus infection: a new era of disease control. Intern Med J (2004) 0.95
Pre-translational regulation of cytochrome P450 genes is responsible for disease-specific changes of individual P450 enzymes among patients with cirrhosis. Biochem Pharmacol (1995) 0.95
Role of oxidative stress in hypoxia-reoxygenation injury to cultured rat hepatic sinusoidal endothelial cells. Hepatology (2000) 0.94
Does steatohepatitis impair liver regeneration? A study in a dietary model of non-alcoholic steatohepatitis in rats. J Gastroenterol Hepatol (1999) 0.92
Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation. AJR Am J Roentgenol (1998) 0.91
Mechanism of azathioprine-induced injury to hepatocytes: roles of glutathione depletion and mitochondrial injury. J Hepatol (2001) 0.91
Age but not gender selectively affects expression of individual cytochrome P450 proteins in human liver. Biochem Pharmacol (1995) 0.91
Influence of clinicopathological variables on CYP protein expression in human liver. J Gastroenterol Hepatol (1996) 0.89
Interferon gamma down-regulates cytochrome P450 3A genes in primary cultures of well-differentiated rat hepatocytes. Hepatology (1996) 0.89
Structural and functional reconstitution of hepatic cytochrome P-450 in vivo. Reversal of allylisopropylacetamide-mediated destruction of the hemoprotein by exogenous heme. J Biol Chem (1980) 0.89
Hepatocellular carcinoma in western Sydney. Aetiology, changes in incidence, and opportunities for better outcomes. Med J Aust (1994) 0.88
Hepatotoxicity from paracetamol self-poisoning in western Sydney: a continuing challenge. Med J Aust (1992) 0.88
Growth hormone treatment increases cytochrome P450-mediated antipyrine clearance in man. J Clin Endocrinol Metab (1996) 0.88
Prospective data collection of off-label use of rituximab in Australian public hospitals. Intern Med J (2013) 0.87
Interferon suppresses erythromycin metabolism in rats and human subjects. Hepatology (1993) 0.87
Drug metabolism in cirrhosis. Selective changes in cytochrome P-450 isozymes in the choline-deficient rat model. Biochem Pharmacol (1986) 0.87
Cytochrome P-450 heme moiety. The specific target in drug-induced heme alkylation. J Biol Chem (1981) 0.87
The central role of sinusoidal endothelial cells in hepatic hypoxia-reoxygenation injury in the rat. Hepatology (1996) 0.86
The effects of cell density, attachment substratum and dexamethasone on spontaneous apoptosis of rat hepatocytes in primary culture. In Vitro Cell Dev Biol Anim (1999) 0.86
Accuracy and clinical utility of simplified tests of antipyrine metabolism. Br J Clin Pharmacol (1984) 0.86
Growth hormone regulation of hepatic cytochrome P450 expression in the rat. Adv Enzyme Regul (1992) 0.85
Downregulation of male-specific cytochrome P450s 2C11 and 3A2 in bile duct-ligated male rats: importance to reduced hepatic content of cytochrome P450 in cholestasis. Hepatology (1995) 0.84
Exogenous heme restores in vivo functional capacity of hepatic cytochrome P-450 destroyed by allylisopropylacetamide. Biochem Biophys Res Commun (1979) 0.84
Hepatitis B in Australia: determinants of intrafamily spread. Aust N Z J Med (1987) 0.84
Constitutive and inducible expression of hepatic CYP2E1 in leptin-deficient ob/ob mice. Biochem Biophys Res Commun (2000) 0.84
Inflammation and altered drug clearance in cancer: transcriptional repression of a human CYP3A4 transgene in tumor-bearing mice. Clin Pharmacol Ther (2008) 0.84
How much does alcohol contribute to the variability of hepatic fibrosis in chronic hepatitis C? J Gastroenterol Hepatol (1998) 0.84
Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease. J Gastroenterol Hepatol (1996) 0.83
Interferon down regulates the male-specific cytochrome P450IIIA2 in rat liver. Mol Pharmacol (1990) 0.83
Effects of portal vein ligation on sex hormone metabolism in male rats: relationship to lowered hepatic cytochrome P450 levels. Gastroenterology (1986) 0.83
Virus and host factors are both important determinants of response to interferon treatment among patients with chronic hepatitis C. J Viral Hepat (1996) 0.83
Downregulation of drug transport and metabolism in mice bearing extra-hepatic malignancies. Br J Cancer (2007) 0.83
Inhibition of antipyrine metabolism by interferon. Br J Clin Pharmacol (1986) 0.82
Chronic ethanol administration to rats decreases receptor-operated mobilization of intracellular ionic calcium in cultured hepatocytes and inhibits 1,4,5-inositol trisphosphate production: relevance to impaired liver regeneration. J Clin Invest (1996) 0.82
Chronic ethanol consumption disrupts complexation between EGF receptor and phospholipase C-gamma1: relevance to impaired hepatocyte proliferation. Biochem Biophys Res Commun (1999) 0.82
Heme enhances hexobarbital metabolism in perfused rat liver after drug-mediated destruction of cytochrome P-450. J Pharmacol Exp Ther (1981) 0.82
Non-alcoholic steatohepatitis: impaired antipyrine metabolism and hypertriglyceridaemia may be clues to its pathogenesis. J Gastroenterol Hepatol (1992) 0.82
Molecular epidemiology of hepatitis C in Australia. J Gastroenterol Hepatol (1998) 0.82
Voriconazole toxicity related to polymorphisms in CYP2C19. Intern Med J (2011) 0.82
Bile acids produce a generalized reduction of the catalytic activity of cytochromes P450 and other hepatic microsomal enzymes in vitro: relevance to drug metabolism in experimental cholestasis. J Gastroenterol Hepatol (1996) 0.81
Hepatocellular proliferation and development of hepatocellular carcinoma: a case-control study in chronic hepatitis C. Hum Pathol (1998) 0.81
Efflux of bilirubin into plasma following hepatic degradation of exogenous heme. Proc Soc Exp Biol Med (1980) 0.81
Can the response to interferon treatment be predicted in patients with chronic active hepatitis C? Aust N Z J Med (1991) 0.81
Impaired bile flow and disordered hepatic calcium homeostasis are early features of halothane-induced liver injury in guinea pigs. Hepatology (1996) 0.80
Coordinated improvement in glucose tolerance, liver steatosis and obesity-associated inflammation by cannabinoid 1 receptor antagonism in fat Aussie mice. Int J Obes (Lond) (2011) 0.80
Current approaches to the diagnosis and management of hepatocellular carcinoma. Clin Exp Med (2005) 0.80
Portal vein ligation selectively lowers hepatic cytochrome P450 levels in rats. Gastroenterology (1983) 0.80